Ledger.Open graph →
SEC Form D · filed February 28, 2014

Aurinia Pharmaceuticals Inc

Offering
$52.0M
Sold
$52.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VICTORIA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Benjamin M. Rovinski · Victoria, British Columbia, CanadaDirectorKurt Von M. Emster · Victoria, British Columbia, CanadaDirectorChris M. Kim · Victoria, British Columbia, CanadaDirectorDonald M. Wyatt · Victoria, British Columbia, CanadaDirectorStephen W. Zaruby · Victoria, British Columbia, CanadaExec · DirectorMichael M. Martin · Victoria, British Columbia, CanadaExec · DirectorDennis M. Bourgeault · Victoria, British Columbia, CanadaExecDaniel M. Park · Victoria, British Columbia, CanadaDirectorRichard M. Glickman · Victoria, British Columbia, CanadaExec · DirectorPeter M. Wijngaard · Victoria, British Columbia, CanadaDirectorKurt Von M. Emster · Victoria, British Columbia, CanadaDirectorBenjamin M. Rovinski · Victoria, British Columbia, CanadaDirectorChris M. Kim · Victoria, British Columbia, CanadaDirectorDonald M. Wyatt · Victoria, British Columbia, CanadaDirectorStephen W. Zaruby · Victoria, British Columbia, CanadaExec · DirectorMichael M. Martin · Victoria, British Columbia, CanadaExec · DirectorDennis M. Bourgeault · Victoria, British Columbia, CanadaExecDaniel M. Park · Victoria, British Columbia, CanadaDirectorRichard M. Glickman · Victoria, British Columbia, CanadaExec · DirectorPeter M. Wijngaard · Victoria, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗